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Abstract
Dimethylsulfoxide (DMSO) is a widely used solvent in biology. It has many applications perhaps the most common of which
is in aiding the preparation of drug solutions from hydrophobic chemical entities. Recent studies have suggested that this
molecule may be able to induce apoptosis in neural tissues urging caution regarding its introduction into humans, for
example as part of stem cell transplants. Here we have used in vitro electrophysiological methods applied to murine brain
slices to examine whether a few hours treatment with 0.05% DMSO (a concentration regarded by many as innocuous) alters
intrinsic excitability properties of neurones. We investigated pyramidal neurones in two distinct brain regions, namely area
CA1 of the hippocampus and layer 2 of perirhinal cortex. In the former there was no effect on resting potential but input
resistance was decreased by DMSO pre-treatment. In line with this action potential count for any level of depolarizing
current stimulus was reduced by ,25% following DMSO treatment. Ih-mediated ‘‘sag’’ was also increased in CA1 pyramids
and action potential waveform analysis demonstrated that DMSO treatment moved action potential threshold towards
resting potential. In perirhinal cortex a decreased action potential output for various depolarizing current stimuli was also
seen. In these cells action potential threshold was unaltered by DMSO but a significant increase in action potential width
was apparent. These data indicate that pre-treatment with this widely employed solvent can elicit multifaceted
neurophysiological changes in mammalian neurones at concentrations below those frequently encountered in the
published literature.
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Introduction
There is frequently a requirement to use non-aqueous solvents
in biological experiments, for example, to dissolve pharmacolog-
ical agents that have a limited aqueous solubility. This manipu-
lation is usually performed by making a concentrated stock
solution in 100% solvent that is subsequently diluted into aqueous
media to generate a final solution for application to the cells, tissue
or organism under investigation. Good experimental design
dictates that the drug-treated group is then compared to a group
treated with only the vehicle containing solution. What is less
frequently considered, however, is what effects do the vehicle
containing solutions produce in their own right.
In biology, the organosulphur, polar, aprotic molecule
dimethylsulphoxide (DMSO) has become unquestionably the
most widely employed solvent, at least for in vitro studies. For
example, the individual chemical constituents of large compound
collections used for high throughput screening in the pharmaceu-
tical industry are universally prepared in DMSO, unless there is
some specific reason not so to do [1]. Although, perhaps without
strong evidential reasons, it has seemingly become a general rule of
thumb in biological folklore that concentrations of 0.1% (v/v)
DMSO or lower are generally biologically innocuous, whereas
concentrations above 1% are likely to be highly undesirable. As
well as being used as solvent, another major use of DMSO in
biology is in the cryopreservation of tissues- a use that leads to the
introduction of considerable amounts of DMSO into humans in
clinical scenarios. DMSO has also been used to enhance cell fusion
events and also to manipulate cell permeability. Many of these
actions are mediated through the interaction of DMSO with the
lipid constituents of biological membranes [2].
Here we have used in vitro brain slice neurophysiology methods
to examine if and how a period of DMSO treatment alters the
core intrinsic excitability (IE) properties of mammalian neurones.
We performed our analyses of two classes of neurone. The first was
the hippocampal CA1 pyramidal cell (CA1-PC), probably the
mammalian brain’s most commonly studied neuronal type [3]. In
addition, we investigated cortical pyramidal neurones in layer 2 of
the perirhinal cortex (PR-L2PC), a cell type proposed to play a
pivotal role in recognition memory [4]. We studied the effects of
0.05% DMSO (v/v) a concentration of ,7 mM, which is half that
employed in very many biological studies. Contrary to widespread
opinion we find that this solvent concentration is not
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experimentally inert, but generates significant changes to the IE of
pyramidal cells in both brain regions, effects which persist beyond
the period of exposure.
Methods
Experimental animals
Male C57BL/6J mice aged 4-5 weeks were used for all
experiments. These animals were group housed and maintained
on a standard 12:12 hour light/dark cycle with access to food and
water ad libitum.
Preparation of brain slices
Preparation of hippocampal slices was performed as previously
described [5]. All animal procedures were approved by the local
ethical committee of the University of Bristol and were in
accordance with schedule 1 of the UK Animals (Scientific
Procedures) Act (1986). In brief, mice were sacrificed by cervical
dislocation and the brain was rapidly removed and transferred to
an ice cold (,4uC), sucrose-based slicing solution comprising (in
mM): sucrose, 189; D-glucose, 10; NaHCO3, 26; KCl, 3; MgSO4,
5; CaCl2, 0.1; NaH2PO4, 1.25, continuously bubbled with
carbogen (95% O2, 5% CO2). The cerebellum and frontal and
dorsal parts were removed with a single scalpel cut. The sample
was then mounted on a metal plate ventral side up and 300 mm
thickness horizontal sections were prepared using a Leica VT1200
vibratome.
Perirhinal slices of 300 mm thickness were also prepared in a
sucrose-based slicing medium and using the same Leica vibratome
employed for hippocampal sections. These slices were isolated
from ‘‘modified coronal’’ sections cut at an angle 45 degrees to the
dorsal-ventral axis.
After sectioning, slices were submerged in a storage vessel which
contained our standard artificial cerebrospinal fluid (aCSF)
consisting of (in mM): NaCl, 124; KCl, 3; NaHCO3, 26; CaCl2,
2; NaH2PO4, 1.25; MgSO4, 1; D-glucose, 10 and equilibrated
with 95% O2 and 5% CO2. The slices were gradually heated to
,32–34uC for 30 minutes, after which they were stored at room
temperature for one hour prior to being treated with either
DMSO (0.05% v/v) or no added compound for 2–5 hours prior to
recording; the slices obtained from each animal were exclusively
allocated to either one or the other of the two described
treatments. For the hippocampus, for example, 19 slices from 13
animals were used for the control group and 13 slices from 8
animals for the DMSO treated group. For neurophysiological
analysis an individual slice was transferred to a submersion style
recording chamber mounted on an Olympus BX51 fixed stage
microscope. The chamber was continuously perfused
(,2 ml.min21) with standard gassed aCSF. The temperature of
the slice was maintained at 3361uC by an in-line solution heating
device coupled to a feedback control circuit. The extracellular
solution used during recording did not contain DMSO, irrespec-
tive of the prior treatment, thus any actions of DMSO we observed
were not an acute effect arising from the presence of DMSO but a
consequence of the previous period of prior exposure.
Electrophysiological methods
IE properties were studied using single cell patch clamp
recording from either CA1-PC or PR-L2PC. The recording
methods employed are very similar to those we used for our
previous studies of intrinsic properties of CA1-pyramidal cells in
Ab-overproducing transgenic mice and healthy aged animals [5]
[6]. Neurones were visually identified using infra-red differential
interference contrast optics. Pipettes were fabricated from
borosilicate glass and were fire polished such that their resistance
was 2.5–4.5 MV when filled with pipette solution. For perirhinal
recordings the pipette solution consisted of (mM): K-gluconate,
145; NaCl, 5; K-HEPES, 10; EGTA, 0.2; Na-GTP, 0.3; Mg-ATP,
4; pH 7.3, 285–290 mOsm. For hippocampal recordings the
electrode solution was a slightly modified version consisting (mM)
K-gluconate, 135; NaCl, 5; K-HEPES, 10; EGTA, 0.2; Na-GTP,
0.3; Mg-ATP, 4; biocytin 13.4; Alexafluor 488, 0.02; pH 7.3, 285–
290 mOsm.
After forming gigaseals and entering the whole cell configura-
tion in voltage-clamp mode, the amplifier was immediately
switched to bridge-mode current-clamp in which all experiments
were performed. The pairing of our pipette solution and aCSF
produces a liquid junction potential error of 15 mV; this was
corrected for arithmetically in all data sets. All recordings were
made using a MultiClamp 700B amplifier (Molecular Devices,
Union City, CA). Data were lowpass filtered (5–10 kHz) and then
digitised (20–100 kHz) and stored on a personal computer using
pClamp10 electrophysiology software.
In vitro electrophysiology protocols and data analysis
Analysis of current-clamp recordings, including action potential
waveform analysis was carried out with custom-written routines
within the Matlab environment. Resting potential (Vrest) was
measured as soon after starting recording as possible. Following
determination of resting potential for all other measurements the
unstimulated membrane potential was set to 280 mV using the
appropriate amount of current injection. This manipulation was
applied because certain intrinsic properties, for example input
resistance and sag, are voltage-dependent.
Membrane resistance was analysed in multiple ways. The first
measure (Rin-exp) assessed resting input resistance independently of
the ‘‘sag’’-producing Ih activation that occurs during hyperpolar-
izing current steps. This was calculated using Ohm’s law from the
amplitude of an infinite time extrapolation of a single exponential
curve fitted to the membrane charging response generated by a
2100 pA current injection. The exponential fit was made between
points at 10 and 95% of peak negative amplitude. This
exponential fit was also used to determine membrane time
constant and to determine one measure of the extent of sag (see
below). The second measure of input resistance (Rin-ss), includes
the contribution from additional Ih activation produced during the
current step. This was calculated using Ohm’s law by determining
the steady-state (post-sag) voltage deflection produced by a 500 ms
2100 pA stimulus. In CA1-PC, the input resistance at -80 mV
(Rin-slope) was also measured (as the reciprocal of slope conduc-
tance) using linear regression of the steady state voltage responses
elicited by a series of 8 low amplitude (250 to+30 pA), 500 ms
duration current steps. Hyperpolarization-activated sag was
measured in two ways. The first measurement (sagsub) simply
expressed the difference between the peak and steady state
hyperpolarizations produced by a 500 ms 2100 pA current
injection as a percentage of the peak hyperpolarization. The
second measure of sag (sagfit) measured the decay in response
relative to the amplitude of the infinite time extrapolation used to
determine Rin-exp. In addition to sag, the amplitude of the sag-
related rebound depolarization was also measured relative to the
pre-stimulus membrane potential. Measurements of impedance
were made as previously described [7]. Briefly, oscillating
subthreshold voltage responses were evoked by a sinusoidal
current injection of constant amplitude (between 620 pA and
650 pA) of linearly increasing frequency starting at 0.5 Hz and
rising to 20 Hz over a period of 30 s. The impedance (sZ) versus
frequency profile was derived by dividing the fast Fourier
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transform of the voltage response by that of the applied sinusoidal
current stimulus: Z (MV) =V(fft)/I(fft). The quality factor of the
oscillator was calculated as the ratio between the impedance at the
peak frequency and the impedance at 1 Hz: (Q=Zpeak/Z1 Hz).
To study suprathreshold behaviours such as firing rates and
patterns and action potential waveforms, depolarizing current
injections of 500 ms duration were used to elicit action potential
(AP) firing. In CA1-PC these varied in amplitude stepwise from +50
to +300 pA in 50 pA increments, whereas in PR-L2PC, which have
a lower input resistance, a larger stimulus range (50–600 pA) was
employed to ensure action potential generation was seen in all cells.
From these data sets the relationship between the stimulus
amplitude and the number and pattern of APs elicited was
examined. Initially to assess individual AP waveforms the first spike
fired by a 300 pA (CA1-PC) or 600 pA (PR-L2PC) current injection
was analysed. In addition, for hippocampal recordings we also
analysed the properties of the first AP in the first sweep in which one
or more AP was observed (which was usually a stimulus below
300 pA). AP threshold was determined from phase plots as the
voltage at which dV/dt surpassed 15 V.s21 [8,9]. Spike width was
measured at 215 mV which is approximately halfway between
threshold (,260 mV) and action potential peak (,+30 mV).
Each parameter investigated was compared between the two
experimental groups using a two tailed unpaired Students t-test or
two way ANOVA, as appropriate.
Results
Effects of DMSO incubation on CA1 pyramidal cells
The zero current potential observed soon after entering the
whole cell mode (an indicator of resting potential) was not different
Figure 1. DMSO pre-treatment modifies subthreshold intrinsic properties in CA1-PC. A) A scatter/box plot of zero current potential
recorded from control and DMSO pre-treated CA1-PC. In this and all other similar plots, the symbols to the left represent data from individual
neurones, whereas the box to the right plots the mean (central symbol) plus the upper and lower bounds of the standard error and the median. In
this and all other figures data from control neurones are presented in black and data from DMSO pre-treated cells are shown in grey. B) A plot of the
average voltage response to both -100 (downwards) and +50 pA (upwards) current stimuli applied to CA1-PC. The thicker central line corresponds to
the mean whereas the two adjacent thinner lines represent the bounds encompassed by 1 standard error of the mean. C) Scatter plots of sub-
threshold intrinsic properties derived from 2100 pA stimuli applied at a fixed membrane potential of 280 mV. Two measurements of input
resistance and sag are presented (see methods).
doi:10.1371/journal.pone.0092557.g001
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when control and DMSO pre-treated CA1-PC were compared
(Figure 1A). Although resting potentials were not different in the
two groups, all further measurements were carried out at a set
membrane potential of 280 mV to reduce variability arising from
the range of resting potentials exhibited by each population (see
Figure 1A).
When subthreshold intrinsic properties were measured using
either positive or negative current injections significant differences
between the control and DMSO pre-treated CA1-PC were clearly
apparent. This is illustrated in Figure 1B which presents mean
voltage responses to injections +50 pA and 2100 pA compiled
from 20 control and 24 DMSO treated cells.
Cell by cell analyses of intrinsic parameters derived from
2100 pA current challenges are presented in Figure 1C. These
confirm that there was a reduction of input resistance of over 30%
in DMSO pre-treated cells. The solvent pre-treated cells also
exhibited an enhanced fractional contribution of sag. This is
perhaps unexpected given the smaller negative voltage deflection
that occurred in these neurones for any current stimulus, which
would typically reduce Ih channel activation. These differences in
both input resistance (P,0.002) and sag were highly significant
(P,0.0003), and remained significant when the single recording
with the highest input resistance in the control group (which might
be considered an outlier) was discounted.
Figure 2. DMSO pre-treatment alters membrane resistance and impedance in CA1-PC. A) Voltage responses from an example control
(middle, black) and DMSO pre-treated (bottom, grey) CA1-PC elicited by a series of 500 ms current stimuli varying in amplitude between 250 and
+30 pA (top). B) Pooled data from a number of recordings like and including those shown in (A). The graph plots steady-state voltage deflection
versus current stimulus. C) A scatter plot of input resistance derived from recordings like that in (A). Each symbol represents the slope-derived input
resistance derived from a straight line fit through all the data points obtained from a single recording, the resistance in DMSO-treated cells was
significantly lower (P,0.001) than in control cells. D) The top panel shows a plot of mean impedance versus stimulus frequency for control (black) and
DMSO-treated (grey) CA1-PC. The thicker central line represents the mean values, and the dashed lines the bounds of 1 SEM. The bottom panel
shows an example trace of the Vm of CA1 pyramidal cell resonating in response of the injection of a sinusoidal current injection of increasing
frequency. The impedance Z(V) is measured as Z = V(fft)/I(fft). The quality factor of the resonator, Q, is calculated as the ratio between the Z at peak
frequency and Z the frequency of 1 Hz (Q=Zpeak/Z1 Hz).
doi:10.1371/journal.pone.0092557.g002
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Fitting an exponential decay function to the voltage trace
between 10% and 95% of the total voltage drop upon the injection
of a 2100 pA current, allowed us to evaluate the membrane time
constant t on a cell by cell basis. In a RC circuit, such as the
plasma membrane, t=Rm.Cm, hence, from this analysis we have
been able to obtain an estimation of Cm, by dividing t by the
extrapolated measure of membrane resistance described above
(see methods).
As well as measurements based on analysis of responses to a
single 2100 pA hyperpolarizing current step, we also measured
input resistance using an escalating series of low amplitude current
injections, varying stepwise between 250 to +30 pA (Figure 2A).
The pooled V-I relationships compiled from these are shown in
Figure 2B. For each recording included in Figure 2B the value of
the slope-derived input resistance (Rin-slope) is presented in
Figure 2C. This reiterates the significant change (P,0.001) in
input resistance produced in CA1-PC by DMSO pre-treatment.
The difference in Rm does not correspond to a difference in t but
in a significant difference in Cm, which is significantly higher in
DMSO-treated slices compared to controls (Table 1).
Using current stimuli consisting of a sine wave linearly
increasing in frequency (see Methods) we obtained measurements
of impedance (i.e. resistance in the AC domain) versus frequency
and therefore of the resonance properties of the cells in the two
different conditions. This measure describes the property of the
cell to either work as a low-pass pass filter (low Q, peak frequency
close to 1 Hz) or as a high-pass filter (high Q, peak frequency
.1 Hz). The resonance properties are mainly related to 2 voltage
gated currents: a) IM, which is an hyperpolarising current activated
upon depolarisation by the opening of voltage-gated potassium
channels (VGKC) and that is selectively abolished by Kv7 blockers,
such as XE991; b) Ih, which is a depolarising current activated
upon hyperpolarisation by the opening of hyperpolarisation-cyclic
nucleotide activated channels (HCN) and that is selectively
blocked by HCN inhibitors such as ZD7288. The reciprocal role
of IM or Ih is strongly related to the resting membrane potential; in
our conditions (Vm fixed at 280 mV) the Ih component prevails
[7]. In the present study we observed a significant increase in the
quality factor of the resonator (p = 0.01) after pre-treatment in
DMSO, a non significant tendency towards increase in the
maximal impedance, and no significant differences in the maximal
frequency (Table 2). This result is consistent with the increase in
sag observed in DMSO treated slices, which may underlie a role
for DMSO in increasing Ih.
We also investigated action potential generation of CA1-PC
cells stimulated with depolarizing current steps lasting 500 ms and
varying in amplitude between 50 and 300 pA. Example traces
from both groups are shown in Figure 3A. The fraction of cells
firing one or more spikes for a given depolarizing stimulus is shown
in Figure 3B. There is a suggestion here, at least with weaker
stimuli, that it is less easy to produce firing in the DMSO pre-
treated cells, as might be expected from their ,30% lower input
resistance. Reduced excitability in DMSO treated CA1-PC is also
indicated by Figure 3C, which plots the number of spikes fired for
any given stimulus; and demonstrates a clear reduction in total
spikes fired for any stimulus after DMSO pre-treatment (P = 0.002,
two way ANOVA). This reduction in spike number was also
reflected in the temporal dynamics of spike firing. Thus, when
instantaneous firing frequency was plotted for each successive
spike interval, the first two, highest frequency, intervals were quite
similar but the DMSO treated cells subsequently accommodated
to a firing frequency around 20% lower than that observed in
control cells. This is illustrated for the action potential firing
dynamics in response to 200 and 300 pA stimuli in Figure 3D.
We also analysed if DMSO pre-treatment produced any change
in action potential waveform in CA1-PC. This was initially
achieved by analysing the waveform of the first action potential
evoked by a 300 pA current stimulus (the strongest stimulus
applied). Average action potential waveforms are presented in
Figure 4A whereas cell by cell analysis of action potential
threshold, peak, rate of rise and width at 215 mV are presented
for the two groups in Figure 4B. This latter analysis revealed that
DMSO pre-treatment altered action potential threshold, moving it
nearer to resting potential (P,0.03). None of the other AP
parameters were significantly different although the almost 6 mV
increase in action potential peak visible in the average waveform of
the DMSO pre-treated group just failed to reach significance with
a p-value of 0.052(Table 3). In order to confirm these effects on AP
properties, the first AP of the first sweep exhibiting at least 1 AP
was analysed. This confirmed the observations made when
analysing the first AP of the 300 pA sweep (Figure 5).
Effects of DMSO on pyramidal cells in perirhinal cortex
Having identified clear effects of DSMO on CA1-PC we were
interested to examine if similar or different consequences were
seen in a different class of neurone. To this end we again employed
brain slice methods to investigate the intrinsic properties of
pyramidal neurones in layer 2 of perirhinal cortex (PR-L2PC).
Although less widely studied at the cellular level, it is clear that
neurophysiologically PR-L2PC behave somewhat differently to
CA1-PC [10]. Furthermore, within their overall population, PR-
L2PC exhibit greater neurophysiological diversity than CA1-PC.
Table 1. Comparison of passive membrane properties of
control CA1 pyramidal neurons with those pre-treated with
DMSO (0.05%).
DMSO 0.05% n=24 aCSF n=20 P
Mean SEM Mean SEM
RMP (mV) 273.8 1.3 273.8 1.9 0.99
Rin-ss (MV) 78.4 5.4 121.3 11.9 0.001
Rin-exp (MV) 110.3 6.9 153.3 16.5 0.014
Rin-slope (MV) 84.6 6.4 141.2 15.0 0.0007
sag_sub (%) 23.5 1.2 16.8 1.5 0.001
sag_fit (%) 29.4 1.2 19.9 2.2 0.0003
tau (ms) 14.3 0.9 13.1 1.1 0.4
Cm fit (pF) 140.9 11.6 99.6 12.9 0.02
doi:10.1371/journal.pone.0092557.t001
Table 2. Comparison of intrinsic resonance properties of
control CA1 pyramidal neurons with those pre-treated with
DMSO (0.05%).
DMSO 0.05% n=24 aCSF n=20 P
Mean SEM Mean SEM
Peak frequency (Hz) 5.2 0.4 4.2 0.5 0.14
Q 1.2 0.03 1.1 0.02 0.02
Peak Z 105.8 9.3 131.6 16.6 0.16
doi:10.1371/journal.pone.0092557.t002
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In this study, however, all PR-L2PC cells are presented together,
to mirror our analysis of CA1-PC
Basic sub-threshold intrinsic properties of PR-L2PC are
presented in Figure 5. Resting potential was ,6 mV more
negative in control PR-L2PC than CA1-PC, something we have
also observed comparing CA1-PC and PR-L2PC in rats (AR, JB
and James Cheliah, unpublished observations). As noted in CA1-
PC (Figure 1A), there was no difference in resting potential
between control and DMSO pre-treated PR-L2PC (Figure 6A),
however, paralleling the hippocampal cells (Figures 1 and 2), the
average input resistance was lower in DMSO pre-treated PR-
L2PC, in this case by around 15%. This effect of DMSO pre-
treatment, however, failed to reach statistical significance
(P,0.09), possibly due to the greater cell to cell variance within
the PR-L2PC population. In control cells, the mean fractional
level of sag in PR-L2PC is much less than that in CA1-PC,
averaging around only 10%. This is something also seen in rats
(AR, JB and James Cheliah, unpublished observations). As
Figure 3. DMSO pre-treatment reduces action potential output in CA1-PC. A) Examples of the action potential firing produced by
application of 500 ms depolarizing stimuli of 100 (left), 200 (middle) and 300 pA (right) amplitude applied at a pre-stimulus membrane potential of
280 mV. Data are show for both a control aCSF only CA1-PC (top) and a DMSO pre-treated CA1-PC (bottom). B) A plot of the percentage of
recordings in which 1 or more action potential was elicited by the various amplitudes of current stimulus indicated on the ordinate. C) A plot of mean
number of spikes versus amplitude of current stimulus for control and DMSO pre-treated CA1-PC. D) A plot of instantaneous action potential
frequency versus spike interval for 500 ms current stimuli of 200 pA (left) and 300 pA (right) amplitude.
doi:10.1371/journal.pone.0092557.g003
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expected, the amount of sag was strongly positively correlated with
the depolarizing rebound potential seen following cessation of the
hyperpolarizing current stimulus (data not shown). Unlike our
observations in CA1-PC (Figure 1C) sag did not increase in PR-
L2PC after DMSO pre-treatment, indeed the mean level was
slightly lower, although not significantly so. Paralleling this, the
post-stimulus rebound potential was also slightly reduced after
DMSO treatment, although again not significantly so.
When PR-L2PC cells at a set membrane potential of 280 mV
were challenged with 500 ms depolarizing current pulses (100–
600 pA) robust spiking was observed. Similar to CA1-PC, as the
stimulus amplitude was increased both the probability of observing
firing and the rate of firing increased. A plot of the fraction of cells
firing for each level of current stimulus applied is shown in
Figure 7A. The mean number of spikes fired for each stimulus is
presented in Figure 7B; as in CA1-PC this demonstrates that
DMSO pre-treatment reduced action potential output across a
range of stimulus intensities (P,0.001, 2 way ANOVA). The
temporal dynamics of spiking patterns are presented for four
example amplitudes (150, 300, 450 and 600 pA) of 500 ms stimuli
Figure 4. DMSO pre-treatment changes action potential threshold in CA1-PC. A) Averaged action potential waveform 6 SEM from 20
control cells (aCSF) and 24 DMSO treated cells. The action potentials were the first spike to fire in response to a 300 pA depolarizing stimulus. B) Cell
by cell analysis of action potential parameters for the action potentials used to compile (A). DMSO caused a negative shift in action potential
threshold (P,0.03).
doi:10.1371/journal.pone.0092557.g004
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in Figure 7C. This indicates that PR-L2PC exhibit near regular
spiking with weaker current stimuli but accommodate with
stronger stimuli. Furthermore, as in CA1-PC, the post-accommo-
dation steady-state firing rate was consistently reduced when the
cells had received DMSO pre-treatment.
Waveform analyses of the first action potential produced by a
600 pA current stimulus are illustrated in Figure 8A. As shown for
CA1-PC in Figure 4B the graphs present a cell by cell analysis of
four different action potential parameters. In contrast to the
hippocampal cells a significant broadening of the action potential
(P,0.002) was seen in the DMSO pre-treated PR-L2PC, whereas
threshold, peak and rate of rise where not altered.
Table 3. A comparison of AP properties in control CA1
pyramidal neurons with those pretreated with DMSO (0.05%).
DMSO 0.05% n=24 aCSF n=20 P
Mean SEM Mean SEM
AP_peak (mV) 34.5 1.5 28.6 2.6 0.05
AP_width (ms) 0.7 0.03 0.7 0.04 0.10
AP_thres (mV) 255.0 0.7 251.7 1.4 0.03
AP_max_dvdt (Vs21) 530.4 18.8 482.8 33.7 0.21
doi:10.1371/journal.pone.0092557.t003
Figure 5. An alternative analysis of the action potential properties reveal the same effects of DMSO pre-treatment on the action
potential threshold in CA1-PC. A) Averaged action potential waveform 6 SEM from 20 control cells (aCSF) and 24 DMSO treated cells. The action
potentials were the first spike to fire in response to the minimal depolarizing stimulus evoking at least 1 action potential. B) Cell by cell analysis of
action potential parameters for the action potentials used to compile (A). DMSO caused a negative shift in action potential threshold (P,0.03).
doi:10.1371/journal.pone.0092557.g005
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Discussion
The experiments presented here indicate that in vitro incubation
of murine brain slices in the aprotic solvent DMSO, at a
concentration frequently regarded as biologically innocuous, can
produce significant changes to neuronal IE. Effects of DMSO
were observed in two different classes of pyramidal neurone, CA1-
PC and PR-L2PC. These cells reside in distinct CNS regions, both
of which have known roles in cognitive function [3,4].
In both neurone types the consequences of DMSO exposure
can simplistically be regarded as a reduction in excitability,
reducing action potential output for any given stimulus (Figures 3C
and 6B). This probably for the most part arises from the reduced
membrane resistance in DMSO exposed cells, which means any
current drive will produce an attenuated voltage response.
Notably, however, in CA1-PC, but not PR-L2PC we also observed
a negative shift in action potential threshold. This potentially acts
to favour action potential generation, and could, under some
circumstances, make it easier to elicit action potential generation.
Most importantly these data confirm the need to employ
appropriate vehicle controls in experiments using a DMSO
vehicle, even at quite modest concentrations. To state the perhaps
obvious conclusion, when seeing an effect(s) in response to
treatment with an agent applied with DMSO it can only be
certain that the effect(s) arise from the agent alone if a comparison
is made to the effect of DMSO alone. Beyond this our data tell us
that neurones in brain slices are no longer behaving ‘‘normally’’
after a period of exposure to DMSO, although this has to be put
within the context of how ‘‘normally’’ neurones behave in an in
vitro preparation such as a brain slice anyway, something we have
discussed previously [11].
It is important to make clear that in these experiments no
DMSO was being applied during the electrophysiological record-
ings themselves. Instead, the solvent treatment was made for 2–
5 hours in the holding chamber employed before the slices were
transferred to the constantly perfused recording chamber.
Furthermore, by the time we established any recording we would
expect any residual DMSO to have washed out of the tissue.
Consequently the actual recordings were made under identical
conditions for both groups. For this reason, the simplest
interpretation is the effects of DMSO were already established
before the brain slice was transferred to the recording chamber,
and also the effects persist at least long enough to outlast the
period between placing the slice in the bath and establishing a
whole-cell recording, a time which probably varies between 5
minutes and 1 or 2 hours.
By studying the effects of DMSO on two different cell types
located in different parts of the limbic system we were able to see if
any commonalities arose. Both cell types are classified as
pyramidal based on their morphology and both are glutamatergic,
however, the intrinsic physiology of CA1-PC and PR-L2PC are
somewhat different as can be seen by comparing the component
parts of Figures1–5 with those of Figures 6–8. For example, CA1-
PC cells have higher resting input resistances, exhibit more HCN-
channel mediated sag, and tend to fire more easily and faster
typically with a somewhat more ‘‘bursty’’ pattern.
In neither cell type was the resting membrane potential altered
by DMSO; this indicates to us that the cells were not in a highly
compromised metabolic state, as this would typically produce a
Figure 6. Effects of DMSO pre-treatment on subthreshold intrinsic properties in PR-L2PC. A) A plot of resting potential from 35 control
cells (aCSF) and 26 DMSO-treated PR-L2PC. B) Average voltage responses to 500 ms duration 2100 and +50 pA current stimuli applied at 280 mV.
Data are from 33 control cells (black) and 30 DMSO-treated cells (grey). The thicker central line corresponds to the mean whereas the two adjacent
thinner lines represent the bounds encompassed by 1 standard error of the mean. C) Cell by cell analysis of input resistance from PR-L2PC derived
from analysis of voltage responses to a 2100 pA current stimulus applied at 280 mV. D) Cell by cell analysis of sag in PR-L2PC derived from analysis
of voltage responses to a 2100 pA current stimulus applied at 280 mV.
doi:10.1371/journal.pone.0092557.g006
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substantial depolarization. A similar argument can also be made
against gross DMSO-mediated damage to the plasma membrane.
DMSO did, however, clearly reduce membrane resistance, in
CA1-PC, and a near-significant trend in this direction was also
observed in PR-L2PC. Of note in this regard, is the fact that
DMSO has been used as a tool to increase cellular permeability
[2]. The underlying basis of this decrease in membrane resistance
is unknown, although a likely explanation for this observation is
that DMSO-treatment increased the number of open ion channels
on the membrane. The identity of these channels is not known,
although given the lack of change in membrane potential one
possible candidate is some form of Cl- conductance, since this
would have little effect on resting potential under the ionic
conditions employed in these recordings, (i.e. the Cl- equilibrium
potential is close to rest). Stimulus-induced increases in surface
expression of Cl- channels have certainly been seen in other
Figure 7. DMSO pre-treatment reduces action potential output in PR-L2PC. A) A plot of the percentage of recordings in which 1 or more
action potential was elicited by the various amplitudes of current stimulus indicated on the ordinate. B) A plot of mean number of spikes versus
amplitude of current stimulus for control and DMSO pre-treated PR-L2PC. C) Mean instantaneous firing frequencies for 4 different levels of current
stimulus ranging from 150 pA (top left) to 600 pA (bottom right).
doi:10.1371/journal.pone.0092557.g007
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systems, for example in response to amyloid beta treatment [12].
In parallel to the decrease in Rin, DMSO appears to cause an
inversely proportional increase in membrane capacitance (Cm),
this may reflect a change in cell size although our suspicion is this
instead reflects a change of the capacitive properties of the bilayer.
A clear change in both cell types studied here was a reduction in
the number of spikes fired for a given current stimulus. This could
well be a consequence of the altered input resistance, as by Ohm’s
law the depolarization produced for any given current stimulus
would be smaller. More unexpected was the increase in sag
conductance seen when 2100 pA current stimuli were applied to
DMSO pre-treated CA1-PC cells. This was the case for both
measures of sag we employed. This outcome is not what would be
expected from the reduced input resistance generated in CA1-PC
by DMSO, since this would reduce the hyperpolarization
produced by the current stimulus and consequently cause
activation of fewer HCN channels, the major conductance that
produces sag. Instead DMSO pre-treatment appears to be
enhancing HCN channel activation. Interestingly, similar concen-
trations of another low molecular weight polar solvent, namely
ethanol, have been reported to enhance gating of both cardiac and
CNS HCN channels and thereby to enhance sag [13,14].
A recent study employing the same mouse strain used here,
found that DMSO dosed via the intraperitoneal route to neonatal
and young mice caused widespread neuronal apoptosis that
developed over a period of a few hours [15]. The anatomical
pattern of damage observed changed with age, however, damage
to the cortical neuropil was very prominent at all ages. The lowest
DMSO dose found to be effective in P7 neonates (0.3 mL/Kg) is
roughly similar to the concentration employed here, assuming the
agent is equally distributed throughout the body. After 8 hours this
dose of DMSO caused a 150% increase in the number of
apoptotic cells [15].
In the same study 0.5 and 1% DMSO were shown to kill
around 50% of cultured hippocampal neurones prepared from P0-
P2 rats, interestingly this effect was absent in cultures in which
extracellular potassium was raised to increase neuronal activity
[15]. Taken together with our finding that DMSO induces
hypoexcitability it is tempting to postulate that changes to IE
contribute to DMSO-induced cell damage and death. Notably
there is a well-established literature describing the role of K+
channels in apoptotic processes [16].
As previously observed, [15] literature on CNS effects of
DMSO exposure is very limited, despite the common use of the
agent both as a solvent for bioactive molecules and a cryoprotec-
tant. Behavioural effects of DMSO have been reported in adult
rats, including actions that might reflect altered cortical and/or
hippocampal activity [17,18]. Importantly significant DMSO
exposure is a consequence of stem cell therapies [19] including
bone marrow transplantation such as that provided to children
with neuroblastoma or Ewing’s sarcoma. This raises the possibility
of CNS damage as an unwanted consequence of such clinical
Figure 8. DMSO pre-treatment broadens action potentials in PR-L2PC. A) Cell by cell analysis of action potential parameters from PR-L2PC.
Data are compiled from the first action potential produced by a 600 pA depolarizing stimulus applied at280 mV to 35 control and 30 DMSO-treated
cells. DMSO treatment produced a significant increase in action potential width of around 25%.
doi:10.1371/journal.pone.0092557.g008
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procedures. Indeed, there are reports that suggest that cryopro-
tectant DMSO given as a component of stem cell transplants has
resulted in neurological damage/outcomes [20–24].
Outside of the CNS there have been suggestions that changes to
cardiovascular function associated with stem cell infusion may
arise from the presence of DMSO [25,26]. Perhaps the changes to
neuronal excitability we describe here have parallels in the
excitability of cardiac myocytes which, after all, in the activity of
voltage-gated Na+, K+ and Ca2+ channels, have a broadly similar
basis to their electrical excitability as neurones.
In laboratory science DMSO is widely used as a solvent for
various compounds including pharmacological and biochemical
reagents, in particular hydrophobic molecules such as those that
can gain access to cell interiors by crossing the plasma membrane.
One example of this is the family of fluorescent dyes used to
indicate Ca2+ concentration inside cells. These molecules, for
example Fura-2, are applied to cells in the form of hydrophobic
esters that can readily cross cell membranes, following which
cellular esterases liberate the active acid moieties that have Ca2+-
dependent fluorescent properties. These esters are usually
dissolved in 100% DMSO and then diluted into aqueous media
before applying to tissue of interest for periods of at least 30
minutes and often longer. For loading cellular monolayers the
DMSO concentration applied is typically 0.1 to 0.5%, however,
even higher concentrations are employed for ‘‘the bolus loading
methods’’ used in vivo or in tissue slices [27]. Our data would
suggest that these treatments when applied to neurones could be
causing long lasting changes to the excitability of the system under
investigation.
In summary, pre-treatment with a modest concentration of the
solvent DMSO was found to have persistent effects on the
excitability of mammalian pyramidal neurones. In future, it will
also be important to examine if other classes of neurone, in
particular cells which mediate neuronal synaptic inhibition exhibit
similar effects. It will also be informative to examine if the
neurophysiological changes we describe here are causally linked to
the generation of DMSO-induced apoptosis in rodents [15].
Irrespective of such links it is clear that DMSO should be used in
experimental science with caution and its various actions
considered when introducing this agent into humans for clinical
purposes such as stem cell therapy.
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